Clinical Trials Browser

Phase 2 × Withdrawn × Esophageal Neoplasms × Clear all

NCT02716688 2023-09-22

S-1 and Radiotherapy for Elderly Esophageal Cancer Patients

Phase 2 Withdrawn

Gastrointestinal

Esophageal Neoplasms

NCT05245760 2022-11-08

CRATER

Phase 2 Withdrawn

Gastrointestinal

Esophageal Neoplasms

NCT03787251 2022-04-19

A Study of Second-line Treatment of Postoperative Recurrence and Metastasis of Esophageal Cancer Treated With Apatinib

Phase 2 Withdrawn

Gastrointestinal

Esophageal Neoplasms

NCT03818997 2020-02-05

DYNAMIC

Phase 2 Withdrawn

Gastrointestinal

Biliary Tract Neoplasms, Esophageal Neoplasms

NCT03234842 2018-12-21

ES01

Phase 2 Withdrawn

Gastrointestinal

Esophageal Neoplasms

NCT03220009 2018-10-03

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Phase 2 Withdrawn

DermatologicGastrointestinalGynecologic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Vaginal Neoplasms, Vulvar Neoplasms

NCT02274012 2017-03-14

Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment

Phase 2 Withdrawn

Gastrointestinal

Esophageal Neoplasms, Neoplasm Metastasis

NCT01301495 2015-06-03

Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus

Phase 2 Withdrawn

Gastrointestinal

Deglutition Disorders, Esophageal Neoplasms, Neoplasms

NCT02033538 2015-03-05

Neoadjuvant Chemotherapy of Nanoparticle Albumin-bound Paclitaxel in Squamous Cell Carcinoma of Esophagus

Phase 2 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02034968 2015-03-05

Nimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal Carcinoma

Phase 2 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT02041819 2015-03-05

Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus

Phase 2 Withdrawn

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT01256203 2014-03-04

Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light

Phase 2 Withdrawn

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Dermatitis, Phototoxic

NCT00636298 2013-11-19

Study of Cetuximab and Bevacizumab in Cancer of the Esophagus After Failure of Patient's First Therapy

Phase 2 Withdrawn

Gastrointestinal

Esophageal Neoplasms

NCT00824811 2012-08-02

Topical Cyclosporine vs. Placebo for Epiphora Associated With Docetaxel

Phase 2 Withdrawn

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Lacrimal Apparatus Diseases, Lung Neoplasms, Endophthalmitis, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Lacerations, Small Cell Lung Carcinoma